glp-1 trends Receptor Agonist Market Size GLP-1 RA prescription trends: January

The future development and availability of biosimilars or generic formulations will be crucial for improving affordability and equitable access

The conversation typically sounds like this: I lost 30 pounds and I feel healthier, but I dont want sex anymore . At first glance, there doesnt seem to be a diagnosable problem: Patients labs look fine, their heart health has improved, their blood sugar is better, and their blood pressure dropped

Cardiovascular and renal benefits of novel diabetes drugs by baseline cardiovascular risk: a systematic review, meta-analysis, and meta-regression

Contraindications and cautions include: Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (absolute contraindication) History of pancreatitis (relative contraindication

Cardiorenal protection: potential of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes